PROGRAM

Conference

Check

List
Advanced Therapeutics
May 11th(Thu) 09:30 - 12:20, Rm.308
  • Session Chair
  • Jun Park Executive Consultant, Bureau of Health Industry Promotion, Korea Health Industry Development Institute
  • CMC-related Regulatory Considerations for Microbiome-Based Therapeutics
  • Jun ParkExecutive Consultant, Bureau of Health Industry Promotion, Korea Health Industry Development Institute
  • 09 : 30 ~ 09 : 50
  • Harnessing the Microbiome for Cancer Immunotherapy
  • Joon Seok ParkInstructor, Department of Immunology, Harvard Medical School
  • 09 : 50 ~ 10 : 20
  • Using Pharmaceutical Meta-Analytical Screening (PMAS) for Personalized Microbiome Solution
  • Yosep JiCEO, HEM Pharma
  • 10 : 20 ~ 10 : 50
  • Next Generation Microbiome Therapeutics: Engineered LBP
  • Yeunghyen KimCTO, Liveome
  • 10 : 50 ~ 11 : 20
  • Translating Microbiome Science into New Drug Development
  • Han Seung LeeChief Operating Officer, KoBiolabs, Inc
  • 11 : 20 ~ 11 : 50
 
Panel Discussion
11 : 50 ~ 12 : 00
  • Session Chair
  • Jun Park Executive Consultant, Bureau of Health Industry Promotion, Korea Health Industry Development Institute
  • Joon Seok Park Instructor, Department of Immunology, Harvard Medical School
  • Yosep Ji CEO, HEM Pharma
  • Yeunghyen Kim CTO, Liveome
  • Han Seung Lee Chief Operating Officer, KoBiolabs, Inc
 

BIO KOREA 2024 PARTNERS

BIO KOREA 2024 SPONSORS